Principal Financial Group Inc Corcept Therapeutics Inc Transaction History

Principal Financial Group Inc

  • $162 Billion
  • Q1 2024

A detailed history of Principal Financial Group Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 526,138 shares of CORT stock, worth $16.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
526,138
Previous 499,686 5.29%
Holding current value
$16.6 Million
Previous $16.2 Million 18.34%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024
BUY
$21.1 - $27.46 $558,137 - $726,371
26,452 Added 5.29%
526,138 $13.3 Million
Q4 2023

Feb 07, 2024
SELL
$24.82 - $32.88 $119,309 - $158,054
-4,807 Reduced 0.95%
499,686 $16.2 Million
Q3 2023

Nov 02, 2023
SELL
$21.97 - $33.8 $512,076 - $787,810
-23,308 Reduced 4.42%
504,493 $13.7 Million
Q2 2023

Aug 07, 2023
SELL
$21.44 - $25.15 $1.25 Million - $1.47 Million
-58,458 Reduced 9.97%
527,801 $11.7 Million
Q1 2023

May 09, 2023
SELL
$19.2 - $24.47 $280,166 - $357,066
-14,592 Reduced 2.43%
586,259 $12.7 Million
Q4 2022

Feb 09, 2023
SELL
$19.95 - $29.96 $216,736 - $325,485
-10,864 Reduced 1.78%
600,851 $12.2 Million
Q3 2022

Nov 09, 2022
SELL
$24.7 - $29.12 $1.14 Million - $1.34 Million
-45,952 Reduced 6.99%
611,715 $15.7 Million
Q2 2022

Aug 10, 2022
BUY
$17.33 - $25.3 $218,236 - $318,602
12,593 Added 1.95%
657,667 $15.6 Million
Q1 2022

May 09, 2022
SELL
$16.53 - $25.21 $60,086 - $91,638
-3,635 Reduced 0.56%
645,074 $14.5 Million
Q4 2021

Feb 09, 2022
SELL
$17.1 - $23.34 $1.42 Million - $1.93 Million
-82,815 Reduced 11.32%
648,709 $12.8 Million
Q3 2021

Nov 09, 2021
SELL
$19.68 - $22.53 $196,662 - $225,142
-9,993 Reduced 1.35%
731,524 $14.4 Million
Q2 2021

Aug 10, 2021
SELL
$19.97 - $24.43 $97,833 - $119,682
-4,899 Reduced 0.66%
741,517 $16.3 Million
Q1 2021

May 10, 2021
BUY
$23.49 - $30.56 $56,375 - $73,344
2,400 Added 0.32%
746,416 $17.8 Million
Q4 2020

Feb 08, 2021
SELL
$16.78 - $27.3 $241,346 - $392,655
-14,383 Reduced 1.9%
744,016 $19.5 Million
Q3 2020

Nov 06, 2020
SELL
$12.46 - $19.98 $346,587 - $555,763
-27,816 Reduced 3.54%
758,399 $13.2 Million
Q2 2020

Aug 05, 2020
SELL
$11.0 - $18.26 $121,418 - $201,553
-11,038 Reduced 1.38%
786,215 $13.2 Million
Q1 2020

May 12, 2020
SELL
$10.11 - $14.04 $314,653 - $436,966
-31,123 Reduced 3.76%
797,253 $9.48 Million
Q4 2019

Feb 05, 2020
BUY
$12.06 - $16.96 $37,892 - $53,288
3,142 Added 0.38%
828,376 $10 Million
Q3 2019

Nov 13, 2019
SELL
$10.41 - $14.66 $135,829 - $191,283
-13,048 Reduced 1.56%
825,234 $11.7 Million
Q2 2019

Aug 12, 2019
SELL
$9.78 - $12.76 $609,646 - $795,407
-62,336 Reduced 6.92%
838,282 $9.35 Million
Q1 2019

May 10, 2019
SELL
$10.03 - $15.71 $145,184 - $227,402
-14,475 Reduced 1.58%
900,618 $10.6 Million
Q4 2018

Feb 14, 2019
SELL
$11.29 - $17.19 $33,599 - $51,157
-2,976 Reduced 0.32%
915,093 $12.2 Million
Q3 2018

Nov 14, 2018
BUY
$12.27 - $15.65 $1.37 Million - $1.74 Million
111,430 Added 13.81%
918,069 $12.9 Million
Q2 2018

Aug 13, 2018
BUY
$15.3 - $19.69 $396,866 - $510,738
25,939 Added 3.32%
806,639 $0
Q1 2018

May 14, 2018
BUY
$14.59 - $25.5 $330,959 - $578,442
22,684 Added 2.99%
780,700 $12.8 Million
Q4 2017

Feb 13, 2018
BUY
$15.77 - $20.72 $11.3 Million - $14.9 Million
719,324 Added 1859.1%
758,016 $13.7 Million
Q3 2017

Nov 02, 2017
BUY
$12.3 - $19.3 $475,911 - $746,755
38,692
38,692 $747,000

Others Institutions Holding CORT

# of Institutions
315
Shares Held
93.8M
Call Options Held
2.02M
Put Options Held
3.24M
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $3.38B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email